<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="31348">Capecitabine</z:chebi> plus <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> combination (XELOX) is the first-line treatment in <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report a case of <z:hpo ids='HP_0011009'>acute</z:hpo>, severe but substantially reversible, neuromuscular and cardiac toxicity following XELOX chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>Muscle biopsy findings were consistent with a toxic <z:hpo ids='HP_0003198'>myopathy</z:hpo> with necrotizing features and vacuolar changes; COX-negative fibers were also present </plain></SENT>
<SENT sid="3" pm="."><plain>The time course could support a main role for <z:chebi fb="0" ids="31348">capecitabine</z:chebi>, which may have some neurotoxic effects (more frequently central), but a detrimental interaction between the two drugs cannot be ruled out and further studies are needed </plain></SENT>
</text></document>